Humana (NYSE:HUM) experienced a 3% price increase last week, which may have been influenced by its recent partnership with Mercy to open new primary care clinics for seniors. This expansion addresses ...

InvestingPro analysis suggests the stock may be undervalued based on its comprehensive ... The ongoing Stars rating lawsuit presents a significant risk to Humana’s financial performance. If the ...

The analysis highlighted that Humana saw ... difference in enrollment changes compared to market averages. Humana’s stock performance and market strategies continue to be closely monitored ...

Jefferies analysts lowered the price target on Humana ... analysis. The price target reduction comes as investors are estimating $22-$24 of earnings per share for 2027, putting the stock at ...

Jefferies analysts lowered the price target on Humana (NYSE ... a Hold rating. The stock, currently trading at $231.98 with a market capitalization of $28 billion, is showing signs of being ...

While robust first-quarter earnings and operational performance were reported ... Unlock comprehensive insights into our analysis of Humana stock in this financial health report.

After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price ...

Humana (NYSE:HUM) recently reported first-quarter earnings, showcasing a revenue increase from USD 29,611 million to USD 32,112 million and a net income rise from USD 741 million to USD 1,244 million.

Molina Healthcare provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare ...

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...

As Trump's sweeping tax-cut and spending bill marches forward, analysts examine how his broad-ranging policies could turn the ...